<meta http-equiv="Content-Type" content="text/html; charset=utf-8"><link type="text/css" rel="stylesheet" href="resources/sheet.css" >
<style type="text/css">.ritz .waffle a { color: inherit; }.ritz .waffle .s4{border-left: none;background-color:#ffffff;}.ritz .waffle .s1{border-right: none;background-color:#ffffff;text-align:left;text-decoration:underline;-webkit-text-decoration-skip:none;text-decoration-skip-ink:none;color:#1155cc;font-family:'Arial';font-size:10pt;vertical-align:bottom;white-space:nowrap;direction:ltr;padding:2px 3px 2px 3px;}.ritz .waffle .s6{background-color:#ffffff;text-align:left;font-weight:bold;color:#000000;font-family:'Arial';font-size:10pt;vertical-align:bottom;white-space:nowrap;direction:ltr;padding:2px 3px 2px 3px;}.ritz .waffle .s7{border-right: none;background-color:#ffffff;text-align:left;color:#000000;font-family:'docs-Roboto',Arial;font-size:10pt;vertical-align:bottom;white-space:nowrap;direction:ltr;padding:2px 3px 2px 3px;}.ritz .waffle .s3{border-left: none;border-right: none;background-color:#ffffff;}.ritz .waffle .s0{background-color:#ffffff;text-align:left;color:#000000;font-family:'Arial';font-size:10pt;vertical-align:bottom;white-space:nowrap;direction:ltr;padding:2px 3px 2px 3px;}.ritz .waffle .s2{border-right: none;background-color:#ffffff;text-align:left;font-weight:bold;color:#000000;font-family:'Arial';font-size:10pt;vertical-align:bottom;white-space:nowrap;direction:ltr;padding:2px 3px 2px 3px;}.ritz .waffle .s5{border-right: none;background-color:#ffffff;text-align:left;color:#000000;font-family:'Arial';font-size:10pt;vertical-align:bottom;white-space:nowrap;direction:ltr;padding:2px 3px 2px 3px;}</style><div class="ritz grid-container" dir="ltr"><table class="waffle" cellspacing="0" cellpadding="0"><thead><tr><th class="row-header freezebar-origin-ltr"></th><th id="1543952095C0" style="width:100px;" class="column-headers-background">A</th><th id="1543952095C1" style="width:100px;" class="column-headers-background">B</th><th id="1543952095C2" style="width:100px;" class="column-headers-background">C</th><th id="1543952095C3" style="width:100px;" class="column-headers-background">D</th></tr></thead><tbody><tr style="height: 20px"><th id="1543952095R0" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">1</div></th><td class="s0" dir="ltr">Vulval Cancer</td><td class="s0" dir="ltr">Source</td><td class="s0 softmerge" dir="ltr"><div class="softmerge-inner" style="width:97px;left:-1px">Joint Doc with BGCS</div></td><td class="s1 softmerge" dir="ltr"><div class="softmerge-inner" style="width:598px;left:-1px"><a target="_blank" href="https://www.rcog.org.uk/globalassets/documents/guidelines/vulvalcancerguideline.pdf">https://www.rcog.org.uk/globalassets/documents/guidelines/vulvalcancerguideline.pdf</a></div></td></tr><tr style="height: 20px"><th id="1543952095R1" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">2</div></th><td></td><td></td><td></td><td></td></tr><tr style="height: 20px"><th id="1543952095R2" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">3</div></th><td class="s2 softmerge" dir="ltr"><div class="softmerge-inner" style="width:398px;left:-1px">Indications for f/u in specialist vulval clinic or by gynae onc</div></td><td class="s3"></td><td class="s3"></td><td class="s4"></td></tr><tr style="height: 20px"><th id="1543952095R3" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">4</div></th><td class="s0" dir="ltr">High grade VIN</td><td></td><td></td><td></td></tr><tr style="height: 20px"><th id="1543952095R4" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">5</div></th><td class="s5 softmerge" dir="ltr"><div class="softmerge-inner" style="width:298px;left:-1px">High grade with with multicentric disease</div></td><td class="s3"></td><td class="s4"></td><td class="s4"></td></tr><tr style="height: 20px"><th id="1543952095R5" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">6</div></th><td class="s5 softmerge" dir="ltr"><div class="softmerge-inner" style="width:198px;left:-1px">VIN and immunosuppressed</div></td><td class="s4"></td><td class="s4"></td><td></td></tr><tr style="height: 20px"><th id="1543952095R6" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">7</div></th><td class="s5 softmerge" dir="ltr"><div class="softmerge-inner" style="width:198px;left:-1px">VIN with Paget&#39;s disease</div></td><td class="s4"></td><td class="s4"></td><td></td></tr><tr style="height: 20px"><th id="1543952095R7" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">8</div></th><td class="s5 softmerge" dir="ltr"><div class="softmerge-inner" style="width:198px;left:-1px">VIN with melanoma in situ</div></td><td class="s4"></td><td class="s4"></td><td></td></tr><tr style="height: 20px"><th id="1543952095R8" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">9</div></th><td></td><td></td><td></td><td></td></tr><tr style="height: 20px"><th id="1543952095R9" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">10</div></th><td class="s2 softmerge" dir="ltr"><div class="softmerge-inner" style="width:298px;left:-1px">Indications for prolonged follow-up</div></td><td class="s3"></td><td class="s4"></td><td class="s4"></td></tr><tr style="height: 20px"><th id="1543952095R10" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">11</div></th><td class="s5 softmerge" dir="ltr"><div class="softmerge-inner" style="width:198px;left:-1px">Paget&#39;s disease of the vulva</div></td><td class="s4"></td><td class="s4"></td><td></td></tr><tr style="height: 20px"><th id="1543952095R11" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">12</div></th><td></td><td></td><td></td><td></td></tr><tr style="height: 20px"><th id="1543952095R12" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">13</div></th><td class="s2 softmerge" dir="ltr"><div class="softmerge-inner" style="width:398px;left:-1px">Indications for urgent referral to cancer centre</div></td><td class="s3"></td><td class="s3"></td><td class="s4"></td></tr><tr style="height: 20px"><th id="1543952095R13" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">14</div></th><td class="s5 softmerge" dir="ltr"><div class="softmerge-inner" style="width:398px;left:-1px">When vulval ca strongly suspected on examination</div></td><td class="s3"></td><td class="s3"></td><td class="s4"></td></tr><tr style="height: 20px"><th id="1543952095R14" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">15</div></th><td></td><td></td><td></td><td></td></tr><tr style="height: 20px"><th id="1543952095R15" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">16</div></th><td class="s2 softmerge" dir="ltr"><div class="softmerge-inner" style="width:198px;left:-1px">Method of diagnositc biopsy</div></td><td class="s4"></td><td class="s4"></td><td></td></tr><tr style="height: 20px"><th id="1543952095R16" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">17</div></th><td class="s5 softmerge" dir="ltr"><div class="softmerge-inner" style="width:798px;left:-1px">Incisional biopsy, avoiding whole lesion removal. consider not suturing visibly diseased skin to prevent increasing depth of invasion</div></td><td class="s3"></td><td class="s3"></td><td class="s3"></td></tr><tr style="height: 20px"><th id="1543952095R17" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">18</div></th><td></td><td></td><td></td><td></td></tr><tr style="height: 20px"><th id="1543952095R18" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">19</div></th><td class="s6" dir="ltr">Treatment</td><td></td><td></td><td></td></tr><tr style="height: 20px"><th id="1543952095R19" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">20</div></th><td class="s5 softmerge" dir="ltr"><div class="softmerge-inner" style="width:398px;left:-1px">WLE of primary tumour with minimum 15mm margin</div></td><td class="s3"></td><td class="s3"></td><td class="s4"></td></tr><tr style="height: 20px"><th id="1543952095R20" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">21</div></th><td class="s5 softmerge" dir="ltr"><div class="softmerge-inner" style="width:698px;left:-1px">Groin node surgery should be undertaken through separate incisions (triple incision technique) to reduce morbidity. </div></td><td class="s3"></td><td class="s3"></td><td class="s3"></td></tr><tr style="height: 20px"><th id="1543952095R21" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">22</div></th><td class="s7 softmerge" dir="ltr"><div class="softmerge-inner" style="width:498px;left:-1px">The incidence of skin bridge recurrence in early-stage disease is low</div></td><td class="s3"></td><td class="s3"></td><td class="s3"></td></tr><tr style="height: 20px"><th id="1543952095R22" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">23</div></th><td class="s5 softmerge" dir="ltr"><div class="softmerge-inner" style="width:1198px;left:-1px">In unifocal tumours of less than 4 cm maximum diameter where there is no clinical suspicion of lymph node involvement, patients can be safely managed by removal of the identified sentinel lymph nodes.</div></td><td class="s3"></td><td class="s3"></td><td class="s3"></td></tr><tr style="height: 20px"><th id="1543952095R23" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">24</div></th><td class="s5 softmerge" dir="ltr"><div class="softmerge-inner" style="width:498px;left:-1px">In lateral tumours, only ipsilateral groin node surgery need initially be performed.</div></td><td class="s3"></td><td class="s3"></td><td class="s3"></td></tr><tr style="height: 20px"><th id="1543952095R24" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">25</div></th><td class="s5 softmerge" dir="ltr"><div class="softmerge-inner" style="width:498px;left:-1px">Contralateral lymphadenectomy may be required if ipsilateral nodes are positive.</div></td><td class="s3"></td><td class="s3"></td><td class="s3"></td></tr><tr style="height: 20px"><th id="1543952095R25" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">26</div></th><td class="s5 softmerge" dir="ltr"><div class="softmerge-inner" style="width:798px;left:-1px">Superficial groin node dissection alone should not be performed, as it is associated with a higher risk of groin node recurrence.</div></td><td class="s3"></td><td class="s3"></td><td class="s3"></td></tr><tr style="height: 20px"><th id="1543952095R26" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">27</div></th><td class="s5 softmerge" dir="ltr"><div class="softmerge-inner" style="width:798px;left:-1px">Groin node dissection should be omitted in stage Ia squamous cancer, verrucous tumour, basal cell carcinoma and melanoma.</div></td><td class="s3"></td><td class="s3"></td><td class="s3"></td></tr><tr style="height: 20px"><th id="1543952095R27" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">28</div></th><td class="s5 softmerge" dir="ltr"><div class="softmerge-inner" style="width:698px;left:-1px">Preservation of the long saphenous vein may reduce both groin wound and subsequent lower limb problems.</div></td><td class="s3"></td><td class="s3"></td><td class="s3"></td></tr><tr style="height: 20px"><th id="1543952095R28" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">29</div></th><td class="s5 softmerge" dir="ltr"><div class="softmerge-inner" style="width:598px;left:-1px">Surgery is the cornerstone of therapy for the groin nodes in women with vulval cancer.</div></td><td class="s3"></td><td class="s3"></td><td class="s3"></td></tr><tr style="height: 20px"><th id="1543952095R29" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">30</div></th><td class="s5 softmerge" dir="ltr"><div class="softmerge-inner" style="width:698px;left:-1px">Individual women who cannot be optimised to enable surgery can be treated with primary radiotherapy.</div></td><td class="s3"></td><td class="s3"></td><td class="s3"></td></tr><tr style="height: 20px"><th id="1543952095R30" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">31</div></th><td class="s5 softmerge" dir="ltr"><div class="softmerge-inner" style="width:698px;left:-1px">Plastic surgery involvement may be required for large defects and when radiotherapy has been used. </div></td><td class="s3"></td><td class="s3"></td><td class="s3"></td></tr><tr style="height: 20px"><th id="1543952095R31" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">32</div></th><td class="s7 softmerge" dir="ltr"><div class="softmerge-inner" style="width:598px;left:-1px">The vulva is a challenging area for wound healing and faecal and urinary diversion is often required.</div></td><td class="s3"></td><td class="s3"></td><td class="s3"></td></tr><tr style="height: 20px"><th id="1543952095R32" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">33</div></th><td class="s5 softmerge" dir="ltr"><div class="softmerge-inner" style="width:698px;left:-1px">Sentinel lymph node biopsy should be offered to all eligible women with squamous carcinoma of the vulva.</div></td><td class="s3"></td><td class="s3"></td><td class="s3"></td></tr><tr style="height: 20px"><th id="1543952095R33" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">34</div></th><td class="s5 softmerge" dir="ltr"><div class="softmerge-inner" style="width:498px;left:-1px">Vulval melanomas need to be jointly managed with the appropriate melanoma MDT.</div></td><td class="s3"></td><td class="s3"></td><td class="s3"></td></tr><tr style="height: 20px"><th id="1543952095R34" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">35</div></th><td class="s5 softmerge" dir="ltr"><div class="softmerge-inner" style="width:598px;left:-1px">Surgery is the cornerstone of therapy for the groin nodes in women with vulval cancer.</div></td><td class="s3"></td><td class="s3"></td><td class="s3"></td></tr><tr style="height: 20px"><th id="1543952095R35" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">36</div></th><td class="s5 softmerge" dir="ltr"><div class="softmerge-inner" style="width:998px;left:-1px">Primary and recurrent vulval cancer does respond to chemotherapy but responses are variable and toxicity may be a problem in this population of patients.</div></td><td class="s3"></td><td class="s3"></td><td class="s3"></td></tr><tr style="height: 20px"><th id="1543952095R36" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">37</div></th><td class="s5 softmerge" dir="ltr"><div class="softmerge-inner" style="width:1498px;left:-1px">Future development of targeted therapy with drugs such as erlotinib through mutation testing may lead to improvement in vulval cancer treatment toxicity benefit ratio and provide effective systemic treatment even for the more infirm patients.</div></td><td class="s3"></td><td class="s3"></td><td class="s3"></td></tr></tbody></table></div>